Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 29

1.

Technique and outcome of post-mastectomy adjuvant chest wall radiotherapy-the role of tissue-equivalent bolus in reducing risk of local recurrence.

Turner JY, Zeniou A, Williams A, Jyothirmayi R.

Br J Radiol. 2016 Jun 21:20160060. [Epub ahead of print]

PMID:
27251295
2.

Efficacy of neoadjuvant bevacizumab added to docetaxel followed by fluorouracil, epirubicin, and cyclophosphamide, for women with HER2-negative early breast cancer (ARTemis): an open-label, randomised, phase 3 trial.

Earl HM, Hiller L, Dunn JA, Blenkinsop C, Grybowicz L, Vallier AL, Abraham J, Thomas J, Provenzano E, Hughes-Davies L, Gounaris I, McAdam K, Chan S, Ahmad R, Hickish T, Houston S, Rea D, Bartlett J, Caldas C, Cameron DA, Hayward L; ARTemis Investigators.

Lancet Oncol. 2015 Jun;16(6):656-66. doi: 10.1016/S1470-2045(15)70137-3. Epub 2015 May 11.

3.

Breast-conserving surgery with or without irradiation in women aged 65 years or older with early breast cancer (PRIME II): a randomised controlled trial.

Kunkler IH, Williams LJ, Jack WJ, Cameron DA, Dixon JM; PRIME II investigators.

Lancet Oncol. 2015 Mar;16(3):266-73. doi: 10.1016/S1470-2045(14)71221-5. Epub 2015 Jan 28. Erratum in: Lancet Oncol. 2015 Mar;16(3):e105.

PMID:
25637340
4.

Fulvestrant plus anastrozole or placebo versus exemestane alone after progression on non-steroidal aromatase inhibitors in postmenopausal patients with hormone-receptor-positive locally advanced or metastatic breast cancer (SoFEA): a composite, multicentre, phase 3 randomised trial.

Johnston SR, Kilburn LS, Ellis P, Dodwell D, Cameron D, Hayward L, Im YH, Braybrooke JP, Brunt AM, Cheung KL, Jyothirmayi R, Robinson A, Wardley AM, Wheatley D, Howell A, Coombes G, Sergenson N, Sin HJ, Folkerd E, Dowsett M, Bliss JM; SoFEA investigators.

Lancet Oncol. 2013 Sep;14(10):989-98. doi: 10.1016/S1470-2045(13)70322-X. Epub 2013 Jul 29.

5.

Osteonecrosis of the jaw and oral health-related quality of life after adjuvant zoledronic acid: an adjuvant zoledronic acid to reduce recurrence trial subprotocol (BIG01/04).

Rathbone EJ, Brown JE, Marshall HC, Collinson M, Liversedge V, Murden GA, Cameron D, Bell R, Spensley S, Agrawal R, Jyothirmayi R, Chakraborti P, Yuille F, Coleman RE.

J Clin Oncol. 2013 Jul 20;31(21):2685-91. doi: 10.1200/JCO.2012.46.4792. Epub 2013 Jun 24.

6.

Training in clinical oncology: results of the Royal College of Radiologists' survey of new consultants.

Benstead K, Gilson D, Hanna L, Radhakrishna G, McAleer J, Bloomfield D, Jyothirmayi R, Campbell A, Booth J.

Clin Oncol (R Coll Radiol). 2012 Dec;24(10):e143-8. doi: 10.1016/j.clon.2012.08.005. Epub 2012 Sep 13.

PMID:
22981545
7.

Case-based discussion: assessment tool or teaching aid?

Jyothirmayi R.

Clin Oncol (R Coll Radiol). 2012 Dec;24(10):649-53. doi: 10.1016/j.clon.2012.07.008. Epub 2012 Aug 11.

PMID:
22892380
8.

Breast-cancer adjuvant therapy with zoledronic acid.

Coleman RE, Marshall H, Cameron D, Dodwell D, Burkinshaw R, Keane M, Gil M, Houston SJ, Grieve RJ, Barrett-Lee PJ, Ritchie D, Pugh J, Gaunt C, Rea U, Peterson J, Davies C, Hiley V, Gregory W, Bell R; AZURE Investigators.

N Engl J Med. 2011 Oct 13;365(15):1396-405. doi: 10.1056/NEJMoa1105195. Epub 2011 Sep 25.

9.

Adjuvant external beam radiotherapy in the treatment of endometrial cancer (MRC ASTEC and NCIC CTG EN.5 randomised trials): pooled trial results, systematic review, and meta-analysis.

ASTEC/EN.5 Study Group, Blake P, Swart AM, Orton J, Kitchener H, Whelan T, Lukka H, Eisenhauer E, Bacon M, Tu D, Parmar MK, Amos C, Murray C, Qian W.

Lancet. 2009 Jan 10;373(9658):137-46. doi: 10.1016/S0140-6736(08)61767-5. Epub 2008 Dec 16. Review.

10.

Accuracy of frozen section diagnosis at surgery in pre- malignant and malignant lesions of the endometrium.

Attard Montalto S, Coutts M, Devaja O, Summers J, Jyothirmayi R, Papadopoulos A.

Eur J Gynaecol Oncol. 2008;29(5):435-40.

PMID:
19051807
11.

Soft tissue sarcoma of the hand or foot: conservative surgery and radiotherapy.

Jyothirmayi R, Sittampalam Y, Harmer C.

Sarcoma. 1999;3(1):17-24. doi: 10.1080/13577149977820.

12.

Extraskeletal osteosarcoma of the orbit.

Jacob R, Abraham E, Jyothirmayi R, Nair MK.

Sarcoma. 1998;2(2):121-4. doi: 10.1080/13577149878082.

13.

An audit of the indications for and techniques of palliative splenic radiotherapy in the UK.

Jyothirmayi R, Coltart S.

Clin Oncol (R Coll Radiol). 2005 May;17(3):192-4.

PMID:
15901004
14.

Pseudomyxoma peritonei.

Harshen R, Jyothirmayi R, Mithal N.

Clin Oncol (R Coll Radiol). 2003 Apr;15(2):73-7. Review.

PMID:
12708714
15.

Oligodendroglioma: clinical profile and treatment results.

Jacob R, Jyothirmayi R, Dalal Y, Nambiar U, Rajan B, Nair MK.

Neurol India. 2002 Dec;50(4):462-6.

16.

Stereotactic radiotherapy for solitary brain metastases.

Jyothirmayi R, Saran FH, Jalali R, Perks J, Warrington AP, Traish D, Ashley S, Hines F, Brada M.

Clin Oncol (R Coll Radiol). 2001;13(3):228-34.

PMID:
11527300
17.

Radiation therapy in the treatment of giant cell tumor of bone.

Nair MK, Jyothirmayi R.

Int J Radiat Oncol Biol Phys. 1999 Mar 15;43(5):1065-9.

PMID:
10192357
18.

Extragonadal germ-cell tumors: a ten-year experience.

Jacob R, Ramadas K, Jyothirmayi R, Kusumakumary P, Nair MK.

Am J Clin Oncol. 1998 Apr;21(2):198-202.

PMID:
9537212
19.

Conservative surgery and radiotherapy in the treatment of spinal cord astrocytoma.

Jyothirmayi R, Madhavan J, Nair MK, Rajan B.

J Neurooncol. 1997 Jul;33(3):205-11.

PMID:
9195492
20.

Radiotherapy in the treatment of solitary plasmacytoma.

Jyothirmayi R, Gangadharan VP, Nair MK, Rajan B.

Br J Radiol. 1997 May;70(833):511-6.

PMID:
9227234
Items per page

Supplemental Content

Loading ...
Write to the Help Desk